Ayala Pharmaceuticals, Inc. Quarterly Revenues in USD from Q1 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Revenues history and growth rate from Q1 2017 to Q2 2023.
  • Ayala Pharmaceuticals, Inc. Revenues for the quarter ending June 30, 2023 was $9K, a 76.3% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. Revenues for the twelve months ending June 30, 2023 was $209K.
  • Ayala Pharmaceuticals, Inc. annual Revenues for 2023 was $13K, a 98.1% decline from 2022.
  • Ayala Pharmaceuticals, Inc. annual Revenues for 2022 was $692K.
  • Ayala Pharmaceuticals, Inc. annual Revenues for 2018 was $6.06M, a 49.6% decline from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $209K $9K -$29K -76.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $238K $4K -$454K -99.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q4 2022 $692K $105K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $91K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $38K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $458K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q2 2018 $1.13M -$1.92M -62.9% May 1, 2018 Jul 31, 2018 10-Q 2018-09-10
Q1 2018 $1.75M -$1.68M -49% Feb 1, 2018 Apr 30, 2018 10-Q 2018-06-07
Q2 2017 $3.05M May 1, 2017 Jul 31, 2017 10-Q 2018-09-10
Q1 2017 $3.43M Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.